| Cesar Z Gonzales, MD | |
|
503 Mcmillan Rd, West Monroe, LA 71291-5327 | |
| (318) 329-4744 | |
| (318) 329-4719 |
| Full Name | Cesar Z Gonzales |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 503 Mcmillan Rd, West Monroe, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629270962 | NPI | - | NPPES |
| Entity Name | Morehouse General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790966638 PECOS PAC ID: 4284528274 Enrollment ID: O20040211000117 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
| Entity Name | Hni Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366735169 PECOS PAC ID: 6406028810 Enrollment ID: O20141118000854 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
| Entity Name | Allegiance Health Center Of Ruston, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831283670 PECOS PAC ID: 3476560939 Enrollment ID: O20180302000398 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
| Entity Name | Hni Medical Services At Glenwood Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669962064 PECOS PAC ID: 0547518920 Enrollment ID: O20180801000659 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
| Entity Name | Tele Med Clinix Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780204305 PECOS PAC ID: 3577958693 Enrollment ID: O20230828001642 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cesar Z Gonzales, MD 503 Mcmillan Rd, West Monroe, LA 71291-8304 Ph: (318) 329-4744 | Cesar Z Gonzales, MD 503 Mcmillan Rd, West Monroe, LA 71291-5327 Ph: (318) 329-4744 |
News Archive
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury.
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
› Verified 9 days ago
Dr. Marshall Vashon Sanson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2309 Arkansas Rd, West Monroe, LA 71291 Phone: 318-397-7000 Fax: 318-737-7203 | |
Amit Warke, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 503 Mcmillan Rd, West Monroe, LA 71291 Phone: 318-329-4474 | |
Stacy Rutledge, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5328 Cypress St, West Monroe, LA 71291 Phone: 318-396-3636 Fax: 318-397-3639 | |
Hunter Harrison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Professional Dr, West Monroe, LA 71291 Phone: 318-966-6535 Fax: 318-322-7319 | |
Dr. George Ronald Woods, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Professional Dr, West Monroe, LA 71291 Phone: 318-387-5244 | |
Mr. Kenneth Paul Metoyer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Regency Pl, West Monroe, LA 71291 Phone: 318-812-9999 Fax: 318-323-9399 | |
Dr. Clyde E Elliott, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 304 Circle Dr, West Monroe, LA 71291 Phone: 318-388-4863 Fax: 318-388-1144 |